Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Low-fat low-osmosis low-residue type enteral nutritional powder for patients with inflammatory bowel diseases

A technology for inflammatory bowel disease and enteral nutrition, applied in the fields of application, function of food ingredients, food ingredients containing inorganic compounds, etc., can solve the problem of prone to abdominal distension, diarrhea, unsuitable low-residue diet, and poor gastrointestinal tolerance. and other problems, to achieve the effect of being beneficial to tolerance and recovery, preventing and treating various diseases, and reducing mechanical stimulation

Active Publication Date: 2015-11-18
THE AFFILIATED HOSPITAL OF QINGDAO UNIV
View PDF3 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] At present, there are "Ansu", "Nengquanquan" and "Ruineng" series of enteral nutrition preparations on the market, which have a high proportion of fat and are suitable for patients with good gastrointestinal function or relatively normal fat metabolism; " The series of enteral nutrition preparations such as "homogenized meal" and "full nutrition" contain dietary fiber and are not suitable for patients who need a low-residue diet; although "Baipre" is a low-fat and low-residue formula, it has , some patients have poor gastrointestinal tolerance and are prone to discomfort such as abdominal distension and diarrhea

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Low-fat low-osmosis low-residue type enteral nutritional powder for patients with inflammatory bowel diseases
  • Low-fat low-osmosis low-residue type enteral nutritional powder for patients with inflammatory bowel diseases
  • Low-fat low-osmosis low-residue type enteral nutritional powder for patients with inflammatory bowel diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031]Example 1 The proportion of protein in this example is 14.8%, the proportion of fat is 8.2%, and the proportion of carbohydrates is 77%. The proportion of fat is low and the proportion of carbohydrates is high, which is more suitable for patients with severe diarrhea or initial oral diet for pancreatitis.

[0032]

Embodiment 2

[0033] Example 2 The proportion of protein in this example is 15.6%, the proportion of fat is 10.3%, and the proportion of carbohydrates is 74%. The proportion of fat is slightly higher, and the proportion of carbohydrates and protein is moderate. Adverse reactions, patients who need further transition.

[0034]

[0035] Clinical case 1 Patient Li, male, 28 years old, had ulcerative colitis for 12 years. This time, he was admitted to the hospital on the 7th due to abdominal pain, diarrhea, and bloody stool. The patient had diarrhea more than ten times a day, all of which were pus and blood stools, dysbacteriosis in the stool, and serum albumin 28g / L. After admission, the Department of Gastroenterology gave symptomatic and supportive treatment.

[0036] In terms of nutrition therapy, short peptide enteral nutrition preparations were given orally first, and the patient’s diarrhea was aggravated due to the high osmotic pressure; then low-fat and low-osmosis enteral nutrition...

Embodiment 3

[0038] Example 3 The proportion of protein in this example is 16.8%, the proportion of fat is 8.2%, and the proportion of carbohydrates is 75%. The proportion of fat is low and the proportion of protein is slightly higher. It is more suitable for patients who need a low-fat and low-residue diet and low serum protein.

[0039]

[0040] Clinical case 1 Patient Zhang, female, 59 years old, suffered from chronic right heart failure. Loss of appetite, nausea, abdominal distension, edema of both lower extremities. The patient usually eats poorly, and the protein intake is insufficient, and severe hypoalbuminemia occurs, and the serum albumin is 26g / L.

[0041] In terms of nutrition therapy, regular fat ratio nutritional formula powder was given, and the patient's abdominal distension became worse. Given the nutritional formula powder in Example 3, this formula has a low fat ratio, a high protein ratio, low osmotic pressure and no residue, which is suitable for the current situat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a low-fat low-osmosis low-residue type enteral nutritional powder for patients with inflammatory bowel diseases. The powder is prepared from protein, fat, carbohydrate, vitamin complex, minerals and epigallocatechin gallate, and does not contain gluten, wherein the protein is supplied by whey protein powder and L-glutamine; the fat is supplied in a mode of long-chain fatty acid and medium-chain fatty acid, and a ratio of (omega-6) to medium-chain fatty acid to (omega-3) to (omega-9) is 40% to 40% to 10% to 10%; and the carbohydrate is maltodextrin. The enteral nutritional powder is suitable for people who are relatively poor in gastroenteric function and easily have diarrhea or people requiring low-fat low-residue diet, such as patients with inflammatory bowel diseases, pancreatitis patients who are in transition of initial oral diet, heart failure patients, patients who initially use enteral nutrition after fasting, patients with cholecystitis or gall-stone, patients subjected to cholecystectomy, obesity people, patients in preparation of bowel surgery, patients after gastrointestinal surgery and the like. The enteral nutritional powder can be used for supplying balanced nutrition support, is easy to brew and store, is convenient to control dosage and osmotic pressure, and can be used for improving the living quality of patients.

Description

technical field [0001] The invention relates to an enteral nutrition powder, in particular to a low-fat, low-osmosis and low-residue type enteral nutrition powder for patients with inflammatory bowel disease, and is suitable for patients with poor gastrointestinal tract function, prone to diarrhea and low-demand People on a low-fat diet. Background technique [0002] Enteral nutrition (EN) support helps maintain the integrity of intestinal mucosal cell structure and function, and is the main direction of clinical nutrition development. Enteral nutrition (EN) support is the route of choice when patients require nutritional support and have a fully or partially functioning gastrointestinal tract. [0003] Inflammatory bowel disease (IBD) refers to chronic intestinal inflammatory diseases of unknown cause, mainly including Crohn's disease (CD) and ulcerative colitis (UC). Inflammatory bowel disease can easily lead to malnutrition, hypoproteinemia, anemia, etc. The principle ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23L1/29A23L33/00
CPCA23V2002/00A23V2200/32A23V2250/2132A23V2250/2116A23V2250/5114A23V2250/1878A23V2250/186A23V2250/062A23V2250/54252A23V2250/1614A23V2250/16A23V2250/1578A23V2250/1642A23V2250/1592A23V2250/161A23V2250/1588A23V2250/1618A23V2250/1598A23V2250/702A23V2250/71A23V2250/712A23V2250/7142A23V2250/708A23V2250/7042A23V2250/7044A23V2250/7052A23V2250/706A23V2250/1944A23V2250/1626
Inventor 马莉何宝国桂仕林韩磊江秀丽
Owner THE AFFILIATED HOSPITAL OF QINGDAO UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com